Your browser doesn't support javascript.
loading
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.
Rundo, Leonardo; Beer, Lucian; Escudero Sanchez, Lorena; Crispin-Ortuzar, Mireia; Reinius, Marika; McCague, Cathal; Sahin, Hilal; Bura, Vlad; Pintican, Roxana; Zerunian, Marta; Ursprung, Stephan; Allajbeu, Iris; Addley, Helen; Martin-Gonzalez, Paula; Buddenkotte, Thomas; Singh, Naveena; Sahdev, Anju; Funingana, Ionut-Gabriel; Jimenez-Linan, Mercedes; Markowetz, Florian; Brenton, James D; Sala, Evis; Woitek, Ramona.
Afiliación
  • Rundo L; Department of Radiology, Cambridge, United Kingdom.
  • Beer L; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Escudero Sanchez L; Department of Radiology, Cambridge, United Kingdom.
  • Crispin-Ortuzar M; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Reinius M; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • McCague C; Department of Radiology, Cambridge, United Kingdom.
  • Sahin H; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Bura V; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Pintican R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Zerunian M; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
  • Ursprung S; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Allajbeu I; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Addley H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Martin-Gonzalez P; Department of Radiology, Cambridge, United Kingdom.
  • Buddenkotte T; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Singh N; Department of Radiology, Cambridge, United Kingdom.
  • Sahdev A; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Funingana IG; Department of Radiology, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Jimenez-Linan M; Department of Radiology, Cambridge, United Kingdom.
  • Markowetz F; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Brenton JD; Department of Radiology and Medical Imaging, County Clinical Emergency Hospital, Cluj-Napoca, Romania.
  • Sala E; Department of Radiology and Medical Imaging, County Clinical Emergency Hospital, Cluj-Napoca, Romania.
  • Woitek R; Department of Radiology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Front Oncol ; 12: 868265, 2022.
Article en En | MEDLINE | ID: mdl-35785153
Background: Pathological response to neoadjuvant treatment for patients with high-grade serous ovarian carcinoma (HGSOC) is assessed using the chemotherapy response score (CRS) for omental tumor deposits. The main limitation of CRS is that it requires surgical sampling after initial neoadjuvant chemotherapy (NACT) treatment. Earlier and non-invasive response predictors could improve patient stratification. We developed computed tomography (CT) radiomic measures to predict neoadjuvant response before NACT using CRS as a gold standard. Methods: Omental CT-based radiomics models, yielding a simplified fully interpretable radiomic signature, were developed using Elastic Net logistic regression and compared to predictions based on omental tumor volume alone. Models were developed on a single institution cohort of neoadjuvant-treated HGSOC (n = 61; 41% complete response to NCT) and tested on an external test cohort (n = 48; 21% complete response). Results: The performance of the comprehensive radiomics models and the fully interpretable radiomics model was significantly higher than volume-based predictions of response in both the discovery and external test sets when assessed using G-mean (geometric mean of sensitivity and specificity) and NPV, indicating high generalizability and reliability in identifying non-responders when using radiomics. The performance of a fully interpretable model was similar to that of comprehensive radiomics models. Conclusions: CT-based radiomics allows for predicting response to NACT in a timely manner and without the need for abdominal surgery. Adding pre-NACT radiomics to volumetry improved model performance for predictions of response to NACT in HGSOC and was robust to external testing. A radiomic signature based on five robust predictive features provides improved clinical interpretability and may thus facilitate clinical acceptance and application.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido